Skip to content
Search

Latest Stories

Two pharmacists sentenced to two years for illegally supplying Class C Drugs

Two pharmacists sentenced to two years for illegally supplying Class C Drugs

They unlawfully supplied over 55 million doses of Class C drugs diazepam, zolpidem, and zopiclone

Southwark Crown Court on Thursday sentenced two pharmacists to two years imprisonment each, suspended for 24 months, after they were found guilty of selling ‘industrial’ quantities of Class C controlled drugs.


Mandip Sidhu (47) of Littleover, Derby and Nabeil Nasr (42) of Cheadle, Greater Manchester, pleaded guilty at an earlier hearing following an investigation by the Criminal Enforcement Unit of the Medicines and Healthcare Products Regulatory Authority (MHRA).

Both Sidhu and Nasr were pharmacists registered with the General Pharmaceutical Council at the time of the offenses, which took place between May 2013 and June 2017. Sidhu was the director of Pharmaceutical Health Limited (PHL) in Derby, while Nasr owned several pharmacies across the North West of England.

Sidhu was sentenced to two years imprisonment on each of five counts of supplying Class C drugs and four months for forgery, all to run concurrently and suspended for 24 months. Additionally, she must complete 200 hours of community service for her role in the illegal supply of diazepam, zolpidem, and zopiclone.

Nasr was given a two-year prison sentence for each of two counts of supplying Class C drugs, diazepam and zopiclone, and one year for each of two counts of wholesale dealing without a wholesale licence. He has also been suspended for 24 months on the condition that he completes 200 hours of community service.

They unlawfully supplied over 55 million doses of Class C controlled drugs, with more than 47 million of those doses being diazepam.

Andy Morling, MHRA Deputy Director (Criminal Enforcement), stated that the sentencing followed a thorough and complex investigation conducted by their Criminal Enforcement Unit.

Sidhu also pleaded guilty to a forgery charge, admitting she made a false invoice to mislead an MHRA inspector into believing the medicines had been sold to a company outside the European Economic Area.

The court heard that PHL, the company where Sidhu was a director, purchased 4.27 million tablets in August 2014 and 4.5 million tablets in March 2015, despite not having legally dispensed any medicines against a prescription since July 19, 2013.

To legally trade in these medicines, pharmacists or wholesale business owners are required to possess a Home Office Controlled Drug Licence (HOCDL). Additionally, the licence must be endorsed by the MHRA before it can be used to buy or sell drugs in high quantities. Despite holding various licences for their work as pharmacists, neither Sidhu nor Nasr held an HOCDL, according to MHRA.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less